Disclosures for "Predictors of Survival in Atypical Parkinsonian Syndromes in a Tunisian Cohort")
-
Dr. Nasri has nothing to disclose.
-
Ikram Sghaier has nothing to disclose.
-
Mrabet Saloua has nothing to disclose.
-
Mr. Abida has nothing to disclose.
-
Alya GHARBI has nothing to disclose.
-
Amira Souissi has nothing to disclose.
-
Mouna BenDjebara has nothing to disclose.
-
Amina Gargouri has nothing to disclose.
-
Dr. Kacem has nothing to disclose.
-
Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Gouider has received research support from Clinical Investigation Center. The institution of Dr. Gouider has received research support from Menactrims.